Acute cardio-renal syndrome: Progression from congestive heart failure to congestive kidney failure

被引:38
作者
Wencker D. [1 ]
机构
[1] Department of Medicine, Section of Cardiovascular Disease, Yale University School of Medicine, New Haven, CT 06510
关键词
Heart Failure; Chronic Kidney Disease; Chronic Heart Failure; Renal Vein; Acute Decompensated Heart Failure;
D O I
10.1007/s11897-007-0031-4
中图分类号
学科分类号
摘要
Over the past few years, acute worsening of renal function has emerged as a powerful and independent predictor of adverse cardiac outcomes among patients hospitalized with acute heart failure exacerbation. This phenomenon has been recently termed acute cardio-renal syndrome. Acute cardio-renal syndrome is not uncommon, affecting roughly one third of acute decompensated heart failure patients. The mechanism of acute cardio-renal syndrome is poorly understood and difficult to elucidate in light of the complex and multifactorial comorbidities associated with acute heart failure syndrome. Acute cardio-renal syndrome is commonly explained by hypoperfusion of the kidney with intravascular volume depletion, hypotension and low flow state ("pre-renal syndrome"). This perception, however, is challenged by the actual hemodynamics present during acute cardio-renal syndrome characterized by hypervolemia, normal cardiac output and elevated filling pressures of the systemic and venous circulation. This review discusses the long-standing and unnoticed evidence in support of the notion that right-sided failure with raised filling pressure of the renal vein by itself can indeed lead to acute worsening renal function with oliguria, azotemia, and reduced glomerular filtration rate. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:134 / 138
页数:4
相关论文
共 34 条
[1]  
McCullough P.A., Soman S.S., Shah S.S., Et al., Risks associated with renal dysfunction in patients in the coronary care unit, J Am Coll Cardiol, 36, pp. 679-684, (2000)
[2]  
Wright R.S., Reeder G.S., Herzog C.A., Et al., Acute myocardial infarction and renal dysfunction: A high-risk combination, Ann Intern Med, 137, pp. 563-570, (2002)
[3]  
Khan N.A., Ma I., Thompson C.R., Et al., Kidney function and mortality among patients with left ventricular systolic dysfunction, J Am Soc Nephrol, 17, pp. 244-253, (2006)
[4]  
Dries D.L., Exner D.V., Domanski M.J., Et al., The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction, J Am Coll Cardiol, 35, pp. 681-689, (2000)
[5]  
Ezekowitz J., McAlister F.A., Humphries K.H., Et al., The association among renal insufficiency, pharmacotherapy, and outcomes in 6427 patients with heart failure and coronary artery disease, J Am Coll Cardiol, 44, pp. 1587-1592, (2004)
[6]  
McAlister F.A., Ezekowitz J., Tonelli M., Armstrong P.W., Renal insufficiency and heart failure: Prognostic and therapeutic implications from a prospective cohort study, Circulation, 109, pp. 1004-1009, (2004)
[7]  
Gottlieb S.S., Abraham W., Butler J., Et al., The prognostic importance of different definitions of worsening renal function in congestive heart failure, J Card Fail, 8, pp. 136-141, (2002)
[8]  
Forman D.E., Butler J., Wang Y., Et al., Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure, J Am Coll Cardiol, 43, pp. 61-67, (2004)
[9]  
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification, Am J Kidney Dis, 39, (2002)
[10]  
Shlipak M.G., Smith G.L., Rathore S.S., Et al., Renal function, digoxin therapy, and heart failure outcomes: Evidence from the digoxin intervention group trial, J Am Soc Nephrol, 15, pp. 2195-2203, (2004)